抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
XL388，≥98% | C23H22FN3O4S | |||
|
|
|||||
|
Taselisib (GDC-0032; RG-7604)，99% | C24H28N8O2 | |||
|
|
|||||
|
AGI-5198，99% | C27H31FN4O2 | |||
|
|
|||||
|
NLG919，99% | C18H22N2O | |||
|
|
|||||
|
GSK 2830371，≥96% | C23H29ClN4O2S | |||
|
|
|||||
|
PX-12，99% | C7H12N2S2 | |||
|
|
|||||
|
AGI-6780，98% | C21H18F3N3O3S2 | |||
|
|
|||||
|
Enasidenib，99% | C19H17F6N7O | |||
|
|
|||||
|
Ivosidenib，99% | C28H22ClF3N6O3 | |||
|
|
|||||
|
MSDC 0160，98% | C19H18N2O4S | |||
|
|
|||||
|
Atglistatin，98% | C17H21N3O | |||
|
|
|||||
|
XEN445，96% | C18H17F3N2O3 | |||
|
|
|||||
|
Cilomilast，≥98% | C20H25NO4 | |||
|
|
|||||
|
SR9243，98% | C31H32BrNO4S2 | |||
|
|
|||||
|
ALLOPURINOL RIBOSIDE，99% | C10H12N4O5 | |||
|
|
|||||
|
Avasimibe，99% | C29H43NO4S | |||
|
|
|||||
|
Nepicastat (SYN-117) HCl，99% | C14H15F2N3S·HCl | |||
|
|
|||||
|
Varespladib (LY315920)，98% | C21H20N2O5 | |||
|
|
|||||
